October 10, 2016 — Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago, including the latest advances in ultrasound.
To expand the clinical utility of ultrasound, Toshiba will be showcasing its comprehensive contrast imaging package on the Aplio 500 Platinum and Aplio 300 Platinum systems. Given the recent U.S. Food and Drug Administration (FDA) approval of ultrasound contrast for characterizing liver lesions in adults and pediatrics, the Aplio Platinum Series’ contrast-enhanced ultrasound capabilities allow clinicians to make more confident diagnoses, and may help reduce the need for additional computed tomography (CT) or magnetic resonance imaging (MRI) exams. The Aplio Platinum Series provides powerful clinical imaging tools for advanced visualization, quantification and intervention. This delivers a less expensive and safer diagnostic imaging option with no radiation.
In addition, live ultrasound scanning will take place on the RSNA show floor for the first time this year and Toshiba will demonstrate the advanced capabilities of its premium ultrasound systems. Live abdominal, thyroid, musculoskeletal (MSK) and vascular imaging will showcase the visualization benefits of technologies like Toshiba’s Superb Micro-Vascular Imaging (SMI) and Shear Wave elastography. The company will also reveal new and intuitive system ergonomics that will help boost productivity during daily routine and complex exams.
For more information: www.medical.toshiba.com
August 24, 2026 
